Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.

Willis J, Lefterova MI, Artyomenko A, Kasi PM, Nakamura Y, Mody K, Catenacci DVT, Fakih M, Barbacioru C, Zhao J, Sikora M, Fairclough SR, Lee H, Kim KM, Kim ST, Kim J, Gavino D, Benavides M, Peled N, Nguyen T, Cusnir M, Eskander RN, Azzi G, Yoshino T, Banks KC, Raymond VM, Lanman RB, Chudova DI, Talasaz A, Kopetz S, Lee J, Odegaard JI.

Clin Cancer Res. 2019 Dec 1;25(23):7035-7045. doi: 10.1158/1078-0432.CCR-19-1324. Epub 2019 Aug 4.

PMID:
31383735
2.

The effects of physical activity on cancer prevention, treatment and prognosis: A review of the literature.

Lugo D, Pulido AL, Mihos CG, Issa O, Cusnir M, Horvath SA, Lin J, Santana O.

Complement Ther Med. 2019 Jun;44:9-13. doi: 10.1016/j.ctim.2019.03.013. Epub 2019 Mar 20. Review.

PMID:
31126580
3.

An Occult Malignancy Behind a Demyelinating Disease: POEMS Syndrome.

Lo Presti S, Kanagarajah P, Pirela D, Morlote D, Cusnir M.

J Investig Med High Impact Case Rep. 2016 Oct 18;4(4):2324709616673389. eCollection 2016 Oct-Dec.

4.

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA.

Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 3. No abstract available.

5.

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Leichman L, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler L, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA.

Ann Oncol. 2015 Dec;26(12):2505. doi: 10.1093/annonc/mdv477. Epub 2015 Oct 21. No abstract available.

6.

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Leichman L, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA.

Ann Oncol. 2015 Sep;26(9):1923-9. doi: 10.1093/annonc/mdv264. Epub 2015 Jun 19. Erratum in: Ann Oncol. 2015 Dec;26(12):2505. Leichman, L [added]. Ann Oncol. 2016 Jun;27(6):1180.

7.

Gastric small-cell carcinoma found on esophagogastroduodenoscopy: a case report and literature review.

Frances N, Zeichner SB, Francavilla M, Cusnir M.

Case Rep Oncol Med. 2013;2013:475961. doi: 10.1155/2013/475961. Epub 2013 Apr 4.

8.

A De Novo Germline APC Mutation (3927del5) in a Patient with Familial Adenomatous Polyposis: Case Report and Literature Review.

Zeichner SB, Raj N, Cusnir M, Francavilla M, Hirzel A.

Clin Med Insights Oncol. 2012;6:315-23. doi: 10.4137/CMO.S10178. Epub 2012 Aug 29.

9.

Inter-tumor heterogeneity.

Cusnir M, Cavalcante L.

Hum Vaccin Immunother. 2012 Aug;8(8):1143-5. doi: 10.4161/hv.21203. Epub 2012 Aug 1. Review.

10.

Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.

Peker D, Martinez AE, Schwartz MA, Cusnir M.

Clin Adv Hematol Oncol. 2012 Mar;10(3):204-6. No abstract available.

PMID:
22402431
11.

Typical bronchial carcinoid metastasizing to the brain: a case presentation.

Zeichner SB, Cusnir M, Francavilla M, Hirzel A.

Case Rep Oncol. 2011 Sep;4(3):602-10. doi: 10.1159/000335557. Epub 2011 Dec 23.

12.

Phase II trial of combined modality therapy with myeloid growth factor support in patients with locally advanced non-small cell lung cancer.

Lilenbaum R, Samuels M, Taffaro-Neskey M, Cusnir M, Pizzolato J, Blaustein A.

J Thorac Oncol. 2010 Jun;5(6):837-40. doi: 10.1097/JTO.0b013e3181d6e141.

13.

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

Kulke MH, Tempero MA, Niedzwiecki D, Hollis DR, Kindler HL, Cusnir M, Enzinger PC, Gorsch SM, Goldberg RM, Mayer RJ.

J Clin Oncol. 2009 Nov 20;27(33):5506-12. doi: 10.1200/JCO.2009.22.1309. Epub 2009 Oct 26.

14.

Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.

Cunningham SC, Cusnir M, Burdick RK, Van Echo DA, Moesinger R.

Clin Adv Hematol Oncol. 2003 Dec;1(12):741-2; discussion 743. No abstract available.

PMID:
16258479
15.

Novel systemic therapy options for hepatocellular carcinoma.

Cusnir M, Patt YZ.

Cancer J. 2004 Mar-Apr;10(2):97-103. Review.

PMID:
15130269

Supplemental Content

Loading ...
Support Center